Implications of Codeine Rescheduling for Hospital Pharmacy Practice and Pain Management

1:00pm Wednesday, 14 February 2018
2:00pm Wednesday, 14 February 2018

From 1 Feburary 2018, all codeine-containing medicines have been upscheduled to Schedule 4 Prescription Only. Attend this webinar to learn why the TGA has made this decision, what it means for your practice and how your health service should respond appropriately. During the webinar we will discuss how to detect potential codeine and other opioid misuse in hospital settings and include an overview of treatment protocols for different levels of pain for patients with varying tolerance or past exposure to opioids.


  • Describe the changes and rationale to scheduling of codeine-containing products
  • Describe principles for hospital pharmacy formulary management with respect to upscheduling of codeine-containing products
  • Identify and explain possible codeine and other opioid misuse or abuse in patients in the hospital setting
  • Describe treatment protocols and medication selection cascades for patients with varying levels of pain and opioid tolerance

This webinar commences at 1.00pm AEST

Registration rates:

Member: Free
Non-member: $50

* You will receive a confirmation email upon completion of your registration. If you do not receive this within 4 hours, you have not completed your registration and your space is not guaranteed. Please contact the secretariat by emailing

$50.00 *
$50.00 *
* Price includes GST where applicable

Contact Information

Additional Information


  • Daniel Lim, BPharm, Senior Pharmacist, Dept Critical Care Medicine, Dept Anaesthesia & Acute Pain Medicine, St Vincent’s Hospital Melbourne

Competency Standards

The program addresses the following pharmacy competency standards:

  • 1.3.1 Comply with statute law, guidelines, codes and standards
  • 1.5.1 Apply expert knowledge and skills
  • 1.5.2 Use reasoning and judgement
  • 3.1.2 Assess medication management practices and needs
  • 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
  • 3.5.2 Promote evidence-based medicine use
  • 4.7.1 Understand and contribute to organisational/corporate and clinical governance

(National Competency Standards Framework for Pharmacists in Australia, 2016)


This activity has been accredited for 1 hour of Group-1 (or 1 CPD credit). Accreditation number is S2018/13